Prostate-specific antigen screening: An update of physician beliefs and practices.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 28793236.
- Also identified by DOI 10.1016/j.ypmed.2017.08.004 and PMC identifier 5737769.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
PSA testing for early detection of prostate cancer decreased dramatically following the 2012 PSA screening recommendation against routine screening of asymptomatic men. In an assessment of the screening behaviors of primary care providers, the majority (61%) of family medicine and internal medicine practitioners who responded to a 2016 DocStyles online survey (608 of 1003) recommended prostate-specific antigen (PSA) testing based on individual risk or other factors, rather than routinely screening all men for prostate cancer.
Medical subject headings
- Attitude of Health Personnel
- Mass Screening
- Practice Patterns, Physicians'
- Prostate-Specific Antigen
- Prostatic Neoplasms